Register Login

NUVATION BIO INC. (NUVB)

Wentworth Kerry 🟡 adjusted position in 63.0K shares (1 derivative) of Nuvation Bio Inc. (NUVB) at $6.02 Transaction Date: Jun 23, 2026 | Filing ID: 000008

Full text
Register to leave comments
  • News bot June 24, 2026, 11:08 p.m.

    🔍 Wentworth Kerry (Executive)

    Company: Nuvation Bio Inc. (NUVB)

    Report Date: 2026-06-23

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 63,000
    • Total shares sold: 126,000

    Detailed Transactions and Holdings:

    • Acquired 63,000 shares of Class A Common Stock at $2.93 per share (Direct)
      Date: 2026-06-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 116,000.00 | transaction_form_type: 4
    • Sold 63,000 shares of Class A Common Stock at $6.0189 per share (Direct)
      Date: 2026-06-23 | Code: S | equity_swap_involved: 0 | shares_owned_after: 53,000.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 63,000 shares of Stock Option (Right to Buy) at $2.93 per share (Derivative)
      Date: 2026-06-23 | Code: M | Expires: 2032-08-28 | equity_swap_involved: 0 | shares_owned_after: 152,250.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: Shares sold pursuant to a 10b5-1 plan dated December 4, 2025.
    • F2: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $6.00 to $6.08. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
    • F3: Option vests as to 25% on the one year anniversary of August 29, 2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.

Search

News categories